Cas no 1187385-61-0 (6-Bromo-2-ethoxy-4-methylquinoline)
6-Bromo-2-ethoxy-4-methylquinoline Chemical and Physical Properties
Names and Identifiers
-
- 6-BROMO-2-ETHOXY-4-METHYLQUINOLINE
- 1187385-61-0
- CS-0211183
- BS-25417
- MFCD12756431
- DTXSID70674994
- DB-369072
- SB68803
- AKOS015834565
- 6-Bromo-2-ethoxy-4-methylquinoline
-
- MDL： MFCD12756431
- Inchi： 1S/C12H12BrNO/c1-3-15-12-6-8(2)10-7-9(13)4-5-11(10)14-12/h4-7H,3H2,1-2H3
- InChI Key： RISONBQHKATDEZ-UHFFFAOYSA-N
- SMILES： BrC1C=CC2C(C=1)=C(C)C=C(N=2)OCC
Computed Properties
- Exact Mass: 265.01000
- Monoisotopic Mass: 265.01023g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 15
- Rotatable Bond Count: 2
- Complexity: 212
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.9
- Topological Polar Surface Area: 22.1?2
Experimental Properties
- PSA: 22.12000
- LogP: 3.70440
6-Bromo-2-ethoxy-4-methylquinoline Customs Data
- HS CODE：2933499090
- Customs Data：
China Customs Code:
2933499090Overview:
2933499090. Other compounds containing quinoline or isoquinoline ring system [but not further fused]. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
6-Bromo-2-ethoxy-4-methylquinoline Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A189008039-10g |
6-Bromo-2-ethoxy-4-methylquinoline |
1187385-61-0 | 95% | 10g |
$403.86 | 2023-09-04 | |
| TRC | B696038-100mg |
6-Bromo-2-ethoxy-4-methylquinoline |
1187385-61-0 | 100mg |
$ 64.00 | 2023-04-18 | ||
| TRC | B696038-250mg |
6-Bromo-2-ethoxy-4-methylquinoline |
1187385-61-0 | 250mg |
$ 81.00 | 2023-04-18 | ||
| TRC | B696038-500mg |
6-Bromo-2-ethoxy-4-methylquinoline |
1187385-61-0 | 500mg |
$ 121.00 | 2023-04-18 | ||
| TRC | B696038-1g |
6-Bromo-2-ethoxy-4-methylquinoline |
1187385-61-0 | 1g |
$ 167.00 | 2023-04-18 | ||
| Chemenu | CM145402-10g |
6-Bromo-2-ethoxy-4-methylquinoline |
1187385-61-0 | 95% | 10g |
$356 | 2021-08-05 | |
| Fluorochem | 215896-1g |
6-Bromo-2-ethoxy-4-methylquinoline |
1187385-61-0 | 95% | 1g |
￡100.00 | 2022-03-01 | |
| Fluorochem | 215896-5g |
6-Bromo-2-ethoxy-4-methylquinoline |
1187385-61-0 | 95% | 5g |
￡300.00 | 2022-03-01 | |
| abcr | AB272595-1 g |
6-Bromo-2-ethoxy-4-methylquinoline; 98% |
1187385-61-0 | 1g |
€178.00 | 2023-04-26 | ||
| abcr | AB272595-1g |
6-Bromo-2-ethoxy-4-methylquinoline, 98%; . |
1187385-61-0 | 98% | 1g |
€178.00 | 2025-04-22 |
6-Bromo-2-ethoxy-4-methylquinoline Related Literature
-
Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
-
Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
Additional information on 6-Bromo-2-ethoxy-4-methylquinoline
Market Research and Analysis Report on 6-Bromo-2-Ethoxy-4-Methylquinoline (CAS No. 1187385-61-0)
The compound 6-Bromo-2-Ethoxy-4-Methylquinoline, identified by the CAS number 1187385-61-0, has emerged as a significant molecule in the field of chemical biology and pharmaceutical research. This quinoline derivative has garnered attention due to its potential applications in drug discovery, particularly in the development of anti-cancer and anti-inflammatory agents. Recent studies have highlighted its promising biological activities, making it a focal point for both academic and industrial research.
The global market for specialty chemicals, including advanced intermediates like 6-Bromo-2-Ethoxy-4-Methylquinoline, is driven by the increasing demand for innovative therapeutic agents. The compound's unique structural features, including the bromine and ethoxy substituents, contribute to its bioactivity and make it a valuable intermediate in the synthesis of complex pharmaceutical compounds. Its versatility in various chemical reactions further enhances its appeal in both research and commercial settings.
From a market perspective, the demand for 6-Bromo-2-Ethoxy-4-Methylquinoline is primarily driven by its role as an intermediate in drug development pipelines. Pharmaceutical companies are increasingly investing in the synthesis and characterization of such compounds to address unmet medical needs. Additionally, the growing emphasis on personalized medicine and targeted therapies has accelerated the exploration of quinoline derivatives like this one.
The supply chain for 6-Bromo-2-Ethoxy-4-Methylquinoline involves specialized chemical manufacturers who cater to the needs of both academic institutions and pharmaceutical companies. Key players in this market are focusing on improving production efficiency while maintaining high standards of quality and regulatory compliance. The competitive landscape is characterized by a mix of established suppliers and emerging players, with innovation being a critical factor for market differentiation.
In terms of future outlook, the market for 6-Bromo-2-Ethoxy-4-Methylquinoline is expected to grow steadily, driven by advancements in synthetic chemistry and increasing R&D investments. Collaborations between academia and industry are also playing a pivotal role in accelerating the translation of research findings into commercial products. As regulatory frameworks continue to evolve, ensuring compliance with global standards will remain a priority for suppliers.
In conclusion, 6-Bromo-2-Ethoxy-4-Methylquinoline represents a promising compound with significant potential in the chemical biology and pharmaceutical sectors. Its role as an intermediate in drug development underscores its importance in addressing critical healthcare challenges. As the market evolves, continued innovation and strategic partnerships will be essential to capitalize on this compound's full potential.
1187385-61-0 (6-Bromo-2-ethoxy-4-methylquinoline) Related Products
- 859938-23-1(4-Quinolinecarbonitrile,2-ethoxy-)
- 5428-69-3( )
- 15113-00-5(2-Methoxy-4-methylquinoline)
- 89446-53-7(Quinoline, 7-bromo-2-methoxy-4-methyl-)
- 802570-92-9(Ethanamine,2-[(4-methyl-2-quinolinyl)oxy]-)
- 15113-01-6(Quinoline,2-ethoxy-4,8-dimethyl-)
- 1187386-11-3(6-Bromo-2-isopropoxy-4-methylquinoline)
- 99455-05-7(6-bromo-2-methoxy-quinoline)
- 1187386-12-4(6-Bromo-2-methoxy-4-methylquinoline)
- 1223559-68-9(7-Bromo-2-ethoxyquinoline)
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier